40371-63-9 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-4-methyl-2-nitroaniline is used as an intermediate in the synthesis of various pharmaceuticals for its potential to contribute to the development of new drugs. Its unique structure allows for the creation of a wide range of compounds with different therapeutic properties.
Used in Organic Chemistry Research:
5-Bromo-4-methyl-2-nitroaniline is used as a research compound in organic chemistry, particularly for studying the reactions and properties of substituted aniline derivatives. This helps in understanding the reactivity and potential applications of similar compounds in various chemical processes.
Used in Dye Industry:
5-Bromo-4-methyl-2-nitroaniline is used as a starting material for the production of dyes, due to its strong yellow color. It can be further modified to create a variety of dyes with different shades and properties, suitable for use in textiles, plastics, and other materials.
Used in Chemical Synthesis:
5-Bromo-4-methyl-2-nitroaniline is used as a building block in the synthesis of other organic compounds, such as pigments, agrochemicals, and specialty chemicals. Its versatility in chemical reactions makes it a valuable component in the creation of a diverse range of products.
Check Digit Verification of cas no
The CAS Registry Mumber 40371-63-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,3,7 and 1 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 40371-63:
(7*4)+(6*0)+(5*3)+(4*7)+(3*1)+(2*6)+(1*3)=89
89 % 10 = 9
So 40371-63-9 is a valid CAS Registry Number.
40371-63-9Relevant academic research and scientific papers
FLAVIN DERIVATIVES
-
, (2011/10/31)
The present invention relates novel flavin derivatives, their use and compositions for use as riboswitch ligands and/or anti-infectives.
HETEROCYCLIC KINASE INHIBITORS
-
Page 168, (2010/02/08)
Compounds having the formula (I) are useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
